Skip to main content
. Author manuscript; available in PMC: 2024 Apr 25.
Published in final edited form as: Scand J Rheumatol. 2022 Aug 2;52(1):96–98. doi: 10.1080/03009742.2022.2103296

Figure 1. Sequential musculoskeletal ultrasound (MSUS) at baseline and after 4 months of follow-up in arthralgia patients at risk for inflammatory arthritis (IA):

Figure 1

(A) patients with subclinical inflammation at baseline; (B) patients without subclinical inflammation at baseline. *Percentage IA development is calculated based on the group at baseline (n = 25 for MSUS+ and n = 27 for MSUS−). In total, 15 patients developed IA within 1 year (n = 10 baseline MSUS+, n = 5 baseline MSUS−).

* percentage IA development is calculated based on the group at baseline (n=25 for MSUS+ and n=27 for MSUS-). In total n=15 patients developed IA within one-year (n=10 baseline MSUS+, n=5 baseline MSUS-).